Allarity Therapeutics to Present at Biomarkers Europe 2023

Allarity will present on development ofseveraldrug-specificDRP®companiondiagnostics, and participate in a panel discussion with speakersfrom Merck and Roche

Related Keywords

New York ,United States ,Boston ,Massachusetts ,London ,City Of ,United Kingdom ,Berlin ,Germany ,Denmark ,Thomas Pedersen ,Thomas Jensen ,Priscila Teixeira ,Anna Maria Lara Coenen Stass ,Jonathan Krell ,Mike Beyer ,Company Contact ,Company Nasdaq ,Merck Kgaa ,Smerud Medical Research International ,Allarity Therapeutics Inc ,Clinical Trial Development And Patient Testing ,Carrotize Pr Communications ,Linkedin ,Sam Brown Inc ,Merck Kga ,Twitter ,Exchange Commission ,Clinical Senior Lecturer At Imperial College London ,Biosample Office ,Nasdaq ,Allarity Therapeutics ,Biomarkers Europe ,Gene Expression Based Biomarker ,Predicting Response ,Oncology Patients ,Clinical Trial Development And Patient ,Clinical Senior Lecturer ,Imperial College London ,Maria Lara Coenen Stass ,Associate Director ,Thinkequity Conference ,Drug Response Predictor ,Companion Diagnostic ,Looking Statements ,Private Securities Litigation Reform Act ,Nasdaq Listing ,Business ,